Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 38, Issue 12, 1999, Pages 1474-1477

  Winsberg, Bertrand G ^a,b   Comings, David E ^c  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dopamine transporter; Drug response; Molecular genetics

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE;

ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; DNA POLYMORPHISM; DOSE CALCULATION; DRUG RESPONSE; GENOTYPE; HOMOZYGOSITY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RATING SCALE; STATISTICAL ANALYSIS;

EID: 0032695572     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199912000-00006     Document Type: Article

References (35)

1. Arranz M, Collier D, Sodhi M et al. (1995), Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346:281-282
2. Caron M (1996), A mouse knockout. Am J Psychiatry 153:1387
3. Comings DE (1996), Polygenetic inheritance of psychiatric disorders. In: Handbook of Psychiatric Genetics, Blum K, Noble EP, Sparks RS, Sheridan P, eds. Boca Raton, FL: CRC Press, pp 235-260
4. Comings DE, Comings BG, Muhleman D et al. (1991), The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 266:1793-1800
5. Comings DE, Gade-Andavolu R, Gonzalez N et al. (1998), Multiple additive associations: a technique for the identification of genes in polygenic disorders. Am J Med Genet 81:489
6. Comings DE, Gade-Andavolu R, Gonzalez N, Blake H, Wu S, MacMurray JP (1999), Additive effect of three adrenergic genes (ADRA2A, ADRA2C, DBH) on ADHD in subjects with Tourette syndrome with and without learning disabilities. Clin Genet 55:160-172
7. Comings DE, Wu H, Chiu C, Ring RH, Dietz G, Muhleman D (1996), Polygenic inheritance of Tourette syndrome, stuttering, ADHD, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, DBH and DAT1. Am J Med Genet 67:264-288
8. Conners CK, Barkley RA (1985), Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 21:809-843
9. Cook EH, Stein MA, Krasowski MD et al. (1995), Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998
10. Daly G, Hawi Z, Fitzgerald M, Gill M (1999), Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mot Psychiatry 4:192-196
11. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999), Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-402
12. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M (1997), Confirmation of association between attention deficit disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311-313
13. Gillis JJ, Gigler JW, Pennington BF, DeFries JC (1992), Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnorm Child Psychol 20:343-348
14. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996), Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking dopamine transporter. Nature 379:606-612
15. Grandy DK, Litt M, Allen L et al. (1989), The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a Taq IRFLP. Am J Hum Genet 45:778-785
16. Hungund BL, Hanna M, Winsberg BG (1978), A sensitive gas Chromatographic method for the determination of methylphenidate (Ritalin) and its major metabolite alpha-phenyl-2-piperidine acetic acid (ritalinic acid) in human plasma using nitrogen-phosphorous detector. Commun Psychopharmacol 2:203-208
17. Kleyn PW, Vessell ES (1998), Genetic variation as a guide to drug development. Science 281:1820-1821
18. La Veist TA (1996), Why we should continue to study race ... but do a better job: an essay on race, racism and health. Ethn Dis 6:21-29
19. LaHoste GJ, Swanson JM, Wigal SB et al. (1996), Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1:121-124
20. Lau EK, Castellanos FK, Tayebi N et al. (1997), Association studies do not show an increased frequency of the 7-fold repeat form of the dopamine 4 receptor polymorphisms in children with attention deficit disorder (ADHD) (abstract). Am J Hum Genet 61:A203
21. Lawford BR, Young DMCD, Rowell JA et al. (1995), Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat Med 1:337-341
22. Richardson E, Kupietz S, Winsberg BG, Maitinsky S, Mendell N (1988), Effects of methylphenidate dosage in hyperactive reading-disabled children, II: reading achievement. J Am Acad Child Adolesc Psychiatry 27:78-87
23. Rowe DC, Stever C, Giedinghagen LN et al. (1998), Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 3:419-426
24. Seeman P, Madras BK (1998), Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 3:386-396
25. Sherman DK, Iacono WG, McGue MK (1997a), Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 36:745-753
26. Sherman DK, McGure MK, Iacono WG (1997b), Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. Am J Psychiatry 154:532-535
27. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998), Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511
28. Stevenson J (1992), Evidence for a genetic etiology in hyperactivity. Behav Genet 22:337-344
29. Thapar A, Hervas A, McGuffin P (1995), Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence. Behav Genet 25:537-544
30. Vandenbergh DJ, Persico AM, Ulh GR (1992), A human dopamine transporter predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq IRFL Ps. Mol Brain Res 15:161-166
31. Van Tol HHM, Wu CM, Guan H-C et al. (1992), Multiple dopamine D4 receptor variants in human population. Nature 358:149-152
32. Waldman ID, Rowe A, Abramowitz S et al. (1998), Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776
33. Winsberg B, Maitinsky S, Kupietz S, Richardson E (1987), Is there dose-dependent tolerance associated with chronic methylphenidate therapy in hyperactive children: oral dose and plasma considerations. Psychopharmacol Bull 23:107-110
34. Winsberg BG, Javitt DC, Silipo G, Doneshka P (1997), Mismatch negativity in hyperactive children: effects of methylphenidate. Biol Psychiatry 42:423-445
35. Winsberg BG, Kupietz SS, Sverd J, Hungrund BL, Young NL (1982), Methylphenidate oral dose plasma concentrations and behavior response in children. Psychopharmacology 76:329-332